Literature DB >> 31571157

The relationship between R wave peak time and left ventricular mass index in patients with end-stage renal disease on hemodialysis.

Macit Kalçık1, Mucahit Yetim2, Tolga Doğan2, Barış Eser3, İbrahim Doğan3, Lütfü Bekar2, Oğuzhan Çelik4, Yusuf Karavelioğlu2.   

Abstract

PURPOSE: Cardiovascular complications have been reported to be the main cause of mortality in patients with end-stage renal disease (ESRD). Although left ventricular hypertrophy is the most common clinical presentation of cardiac remodeling, cardiovascular complications may also include disturbances of the heart conduction system. The R wave peak time (RWPT) has been previously associated with left ventricular hypertrophy and myocardial ischemia. In this study, we aimed to investigate the relationship between RWPT and echocardiographic parameters in patients with ESRD.
METHODS: This study enrolled 66 patients (29 females, age 57.2 ± 12.8 years) with ESRD, and 72 controls (37 females, age 55.3 ± 10.1 years) with similar risk factors. All patients underwent electrocardiography and transthoracic echocardiography. The RWPT was defined as the interval between the onset of the QRS complex and the peak of the R or R' wave.
RESULTS: There was no significant difference in terms of clinical and demographic parameters between ESRD patients and controls. Left ventricular ejection fraction was similar between the groups. However, left atrial diameter, interventricular septal thickness, posterior wall thickness, left ventricular mass (LVM) and left ventricular mass index (LVMI) were significantly higher in patients with ESRD. Among electrocardiographic parameters, P wave and QRS complex durations and RWPT were significantly higher in patients with ESRD. Prolonged RWPT, increased LVM and LVMI were identified as associates of ESRD. Furthermore, RWPT correlated well with LVM and LVMI.
CONCLUSION: The present study demonstrated that RWPT prolonged significantly in patients with ESRD. Furthermore, prolonged RWPT has been associated with increased LVM and LVMI.

Entities:  

Keywords:  Echocardiography; Electrocardiography; End-stage renal disease; R wave peak time

Year:  2019        PMID: 31571157     DOI: 10.1007/s11255-019-02297-w

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  44 in total

1.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Charles A Herzog; Richard W Asinger; Alan K Berger; David M Charytan; Javier Díez; Robert G Hart; Kai-Uwe Eckardt; Bertram L Kasiske; Peter A McCullough; Rod S Passman; Stephanie S DeLoach; Patrick H Pun; Eberhard Ritz
Journal:  Kidney Int       Date:  2011-07-13       Impact factor: 10.612

2.  Echocardiographic impact of hydration status in dialysis patients.

Authors:  Isabel Juan-García; María J Puchades; Rafael Sanjuán; Isidro Torregrosa; Miguel Á Solís; Miguel González; Marisa Blasco; Antonio Martínez; Alfonso Miguel
Journal:  Nefrologia       Date:  2012-01-12       Impact factor: 2.033

3.  QRS alterations immediately following production of left ventricular free-wall ischemia in dogs.

Authors:  R L Hamlin; F S Pipers; H K Hellerstein; C R Smith
Journal:  Am J Physiol       Date:  1968-11

Review 4.  What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry.

Authors:  Fahad Saeed; Susana Arrigain; Jesse D Schold; Joseph V Nally; Sankar Dass Navaneethan
Journal:  Nephron       Date:  2018-11-21       Impact factor: 2.847

5.  P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation.

Authors:  N Ozer; K Aytemir; E Atalar; E Sade; S Aksöyek; K Ovünç; T Açýl; N Nazlý; F Ozmen; A Oto; S Kes
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

Review 6.  Cardiovascular consequences of renal anaemia and erythropoietin therapy.

Authors:  K U Eckardt
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

7.  The QRS complex during myocardial ischemia. An experimental analysis in the porcine heart.

Authors:  R P Holland; H Brooks
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

Review 8.  US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; Patrick Albertus; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Jie Cao; Joline L T Chen; Elizabeth Cope; Sai Dharmarajan; Xue Dietrich; Ashley Eckard; Paul W Eggers; Charles Gaber; Daniel Gillen; Debbie Gipson; Haoyu Gu; Susan M Hailpern; Yoshio N Hall; Yun Han; Kevin He; Paul Hebert; Margaret Helmuth; William Herman; Michael Heung; David Hutton; Steven J Jacobsen; Nan Ji; Yan Jin; Kamyar Kalantar-Zadeh; Alissa Kapke; Ronit Katz; Csaba P Kovesdy; Vivian Kurtz; Danielle Lavalee; Yi Li; Yee Lu; Keith McCullough; Miklos Z Molnar; Maria Montez-Rath; Hal Morgenstern; Qiao Mu; Purna Mukhopadhyay; Brahmajee Nallamothu; Danh V Nguyen; Keith C Norris; Ann M O'Hare; Yoshitsugu Obi; Jeffrey Pearson; Ronald Pisoni; Brett Plattner; Friedrich K Port; Praveen Potukuchi; Panduranga Rao; Kaitlyn Ratkowiak; Vanessa Ravel; Debabrata Ray; Connie M Rhee; Douglas E Schaubel; David T Selewski; Sally Shaw; Jiaxiao Shi; Monica Shieu; John J Sim; Peter Song; Melissa Soohoo; Diane Steffick; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Anca Tilea; Lan Tong; Megan Turf; Dongyu Wang; Mia Wang; Kenneth Woodside; April Wyncott; Xin Xin; Wei Zang; Lindsay Zepel; Sai Zhang; Hui Zho; Richard A Hirth; Vahakn Shahinian
Journal:  Am J Kidney Dis       Date:  2017-03       Impact factor: 8.860

Review 9.  Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.

Authors:  Marie-Luise Gross; Eberhard Ritz
Journal:  Semin Dial       Date:  2008-07-08       Impact factor: 3.455

Review 10.  Left ventricular hypertrophy in renal disease: beyond preload and afterload.

Authors:  Eberhard Ritz
Journal:  Kidney Int       Date:  2009-04       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.